Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial

Autor: Valiente, Adoración, de Cueto, Marina, Rodríguez, Ángel, Molina, José, Fischer, Julia, Paul, Gregor, Gallien, Sébastien, Fihman, Vincent, Lacasse, Marion, Coustillères, Francois, Becker, Christian, Fuchs, André, Morata, Laura, Weis, Sebastian, Ponscarme, Diane, Khatchatourian, Lydie, Rouveix, Elisabeth, Merrien, Dominique, Lecomte, Raphaël, Veenemans, Jacobien, Vilchez, Helem H., Kessel, Johanna, Bonten, Marc J.M., Rupp, Jan, Hocqueloux, Laurent, Lucht, Frederic, Stahl, Jean-Paul, Vlek, Anne, Prinz-Langenohl, Reinhild, Tolsma, Violaine, Kaasch, Achim J *, López-Cortés, Luis Eduardo, Rodríguez-Baño, Jesús, Cisneros, José Miguel, Dolores Navarro, M, Fätkenheuer, Gerd, Jung, Norma, Rieg, Siegbert, Lepeule, Raphaël, Coutte, Laetitia, Bernard, Louis, Lemaignen, Adrien, Kösters, Katrin, MacKenzie, Colin R, Soriano, Alex, Hagel, Stefan, Fantin, Bruno, Lafaurie, Matthieu, Talarmin, Jean-Philippe, Dinh, Aurélien, Guimard, Thomas, Boutoille, David, Welte, Tobias, Reuter, Stefan, Kluytmans, Jan, Martin, Maria Luisa, Forestier, Emmanuel, Stocker, Hartmut, Vitrat, Virginie, Tattevin, Pierre, Rommerskirchen, Anna, Noret, Marion, Adams, Anne, Kern, Winfried V, Hellmich, Martin, Seifert, Harald
Zdroj: In The Lancet Infectious Diseases May 2024 24(5):523-534
Databáze: ScienceDirect